公开(公告)号：US20230233679A1

公开(公告)日：2023-07-27

申请号：US17923283

申请日：2021-05-04

Applicant: SIGILON THERAPEUTICS, INC.

Inventor： Hozefa Bandukwala ,  David E. Moller ,  David Peritt

IPC: A61K39/00 ,  A61K9/00 ,  A61K39/39 ,  A61K39/215 ,  A61K39/21 ,  A61K39/245 ,  A61K39/155 ,  A61K9/48 ,  A61K9/06

CPC classification number: A61K39/4634 ,  A61K39/4635 ,  A61K9/0024 ,  A61K39/39 ,  A61K39/215 ,  A61K39/21 ,  A61K39/245 ,  A61K39/155 ,  A61K9/4808 ,  A61K9/06 ,  A61K9/4866 ,  A61K2039/55522

Abstract: Described herein are implantable devices comprising cells engineered to express and secrete antigens of infectious agents. The devices are useful for inducing protective immune responses against infectious agents.